Enteric Campylobacteriosis
1 clinical trials · Condition
◉ Watch Enteric Campylobacteriosis
| Record | Firm | Date |
|---|---|---|
| Efficacy of Rifaximin in Preventing Campylobacteriosis (NCT02280044) | Johns Hopkins Bloomberg School of Public Health | 2014-10-01 |
Track Enteric Campylobacteriosis automatically
Every clearance here is in the API, with alerts when new ones post.